IP Library Patent Application 11186745
Patent Application
App. No. 11/186,745

Device and method for treating ischemic heart disease

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
11/186,745
Abstract

A narrowing intraluminal stent is disclosed and comprises a hollow body and a flow passage therethrough, the hollow body designed for intraluminal placement and having at least one portion of an inner cross sectional dimension smaller than the cross sectional dimension of the lumen, so as to artificially narrow a passage through the body lumen. A method of artificially narrowing a passage through a body lumen using the stent is also disclosed.

Claims (22)

1 . A method of affecting blood flow in coronary vessels, comprising:

(a) transvascularly guiding a catheter to a coronary sinus; and

(b) narrowing a cross-sectional dimension of a flow lumen of said coronary sinus using said catheter.

2 . A method according to claim 1 , wherein narrowing comprises deploying a flow reducer in said coronary sinus.

3 . A method according to claim 2 , wherein deploying comprises deploying using a balloon.

4 . A method according to claim 2 , wherein deploying comprises deploying a self-expanding reducer.

5 . A method according to claim 1 , wherein narrowing comprises narrowing in a manner that increases back pressure.

6 . A method according to claim 1 , wherein narrowing comprises narrowing in a manner that initiates angiogenesis.

7 . A method according to claim 1 , wherein narrowing comprises narrowing in a manner that accelerates angiogenesis.

8 . A method according to claim 1 , wherein narrowing comprises narrowing in a manner that prevents ischemic heart disease.

9 . A method according to claim 1 , wherein narrowing comprises permanently narrowing.

10 . A method according to claim 1 , comprising:

determining that a patient has ischemic heart disease; and

performing (a)-(b).

11 . A method according to claim 1 , comprising reducing said a diameter of said cross-section by a factor of at least 2.6.

12 . A method of improving perfusion of a tissue, comprising:

(a) identifying a tissue having a deficient degree of blood flow there through; and

(b) transvascularly narrowing a cross-sectional diameter of a vessel carrying blood from said tissue.

13 . A method according to claim 12 , wherein said vessel comprises a coronary sinus.

14 . A method according to claim 12 , wherein said tissue comprises cardiac tissue.

15 . A method according to claim 12 , wherein said narrowing is sufficient to cause angiogenesis in said tissue.

16 . A method according to claim 12 , wherein narrowing comprises implanting a flow reducer in said vessel.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 28, 2024
From: NEOVASC MEDICAL LTD.
To: SHOCKWAVE MEDICAL, INC.
Reel/Frame 066942/0164 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 26, 2015
From: SHALEV, ILAN
To: HALPERIN, HAIM
Reel/Frame 034815/0763 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 26, 2015
From: NEOVASC INC.
To: NEOVASC MEDICAL LTD.
Reel/Frame 034815/0803 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 26, 2015
From: HALPERIN, HAIM
To: NEOVASC INC.
Reel/Frame 034817/0195 →